Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
21.22
+1.61 (8.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Surgery Partners Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Surgery Partners stock have an average target of 37.38, with a low estimate of 28 and a high estimate of 50. The average target predicts an increase of 76.15% from the current stock price of 21.22.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SGRY stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 5 | 4 | 4 | 4 | 3 | 3 |
| Hold | 1 | 1 | 1 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 7 | 7 | 9 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $38 → $28 | Hold | Maintains | $38 → $28 | +31.95% | Dec 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $49 → $35 | Buy | Maintains | $49 → $35 | +64.94% | Nov 20, 2024 |
| Macquarie | Macquarie | Buy Maintains $34 | Buy | Maintains | $34 | +60.23% | Nov 19, 2024 |
| Macquarie | Macquarie | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | +60.23% | Nov 13, 2024 |
| Macquarie | Macquarie | Buy Maintains $35 | Buy | Maintains | $35 | +64.94% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
3.14B
from 2.74B
Increased by 14.46%
Revenue Next Year
3.45B
from 3.14B
Increased by 9.94%
EPS This Year
0.91
from -0.09
EPS Next Year
1.02
from 0.91
Increased by 12.32%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.2B | 3.6B | 4.0B | |
| Avg | 3.1B | 3.5B | 3.8B | |
| Low | 3.0B | 3.3B | 3.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 18.3% | 14.9% | 15.3% | |
| Avg | 14.5% | 9.9% | 9.3% | |
| Low | 9.9% | 4.4% | 3.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.34 | 1.66 | 1.89 | |
| Avg | 0.91 | 1.02 | 1.29 | |
| Low | 0.74 | 0.56 | 0.87 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 82.2% | 84.8% | |
| Avg | - | 12.3% | 26.5% | |
| Low | - | -38.7% | -14.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.